Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE2
Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout
- Status
- COMPLETED
- Phase
- PHASE2
Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura
- Status
- COMPLETED
- Phase
- PHASE3
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074)
- Status
- COMPLETED
- Phase
- PHASE1
Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Dexamethasone Treatment of Congenital Adrenal Hyperplasia
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)
- Status
- COMPLETED
- Phase
- PHASE3
Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2
The Effects of Dexamethasone on the Duration of Sciatic Nerve Blocks
- Status
- TERMINATED
- Phase
- NA
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3